Genetics of Dyslipidemia

Pascale Benlian · Kluwer Academic Publishers · 2001
Profound mortality rates, due to cardiovascular disease, are a worldwide problem. Cardiovascular disease results from complications of a silent and chronic arterial disease: atherosclerosis. The challenge for the
practitioner is adapting diagnostic and therapeutic responses to prevent this common and complex disease.
Dyslipidemia, are disorders of the metabolism of soluble transporters of lipids in extracellular spaces
of the human body (including blood), called lipoproteins. They are major cardiovascular risk factors, causally related with atherosclerosis and are themselves multifactorial diseases, resulting from interactions between
genetic and environmental factors.
The study of genetic factors has recently taken a new path with the study of DNA as an experimental object. More than fifty genes of lipoprotein metabolism have been
identified in both their physiological actions and their contribution to the pathogenesis of human dyslipidemia. The diversity of observations has refined our current knowledge of the control of lipid metabolism and energy
homeostasis in living organisms beyond the limits of the cardiovascular system (e.g., brain, immune system, and development). These studies have given way to a shake-up of former phenotypic classifications, distinguishing
new entities, defining targeted therapeutic strategies, providing a basis for different patterns of disease distribution in human populations.
Uus kasutamata raamat
Detailid
- Autor
- Pascale Benlian
- ISBN
- 9780792373629
- Aasta
- 2001
- Kirjastus
- Kluwer Academic Publishers
- Keel
- inglise
- Köide
- Kõva kaas
- Lehekülgi
- 315
- Teema
- Meditsiin › Prekliinilised alusteadused — Pre-clinical medicine: basic sciences
- Kaal
- 658 g